Home2024-10-02T10:25:57+02:00

BIOmarker based diagnostic TOOLkit to personalize pharmacological approaches in congestive heart failure

BIOTOOL-CHF Project Video

0
Partners
0
Duration
0
EU Contribution

Project

The innovation potential of BIOTOOL-CHF is built on the overall approach that will be adopted to tackle the unsolved issue of improving the efficiency of fluid management in systolic heart failure

Objectives

BIOTOOL-CHF will discover, develop, and validate a personalised approach to manage diuretic therapy in heart failure and reduced ejection fraction, to reduce heart failure hospitalizations and improve quality of life

Impacts

BIOTOOL-CHF gathers major European heart failure and big data analysis experts to provide an innovative approach to the management patients with heart failure and reduced ejection fraction, which is one of the most frequent, costly and deadly pathological conditions in Europe

PARTNERS INVOLVED

BIOTOOL-CHF partners join forces to change the paradigm of heart failure with reduced ejection fraction pharmacological therapy, by developing a personalised strategy to target congestion with diuretics.

Go to Top